United States
Print page content Print
Increase text size Decrease text size
Text Size

FluSure® Pandemic

The ONLY commercial vaccine for pH1N1

FluSure® Pandemic is the ONLY commercial vaccine to help protect pigs from pandemic H1N1.

More than 20% of SIV samples genetically sequenced in 2010 at the University of Minnesota Veterinary Diagnostic Laboratory were pandemic H1N1.1 

Zoets was first to receive USDA conditional license in 2009; full license was gained in 2010.

1. Of the 134 SIV viruses characterized by the University of Minnesota Veterinary Diagnostic Laboratory in 2010, 22.4% were pandemic H1N1. 

 

Expand All
  • FluSure® Pandemic adds another valuable swine influenza management tool in the FluSure®  XP Defense System and is the only full licensed vaccine on the market to product against pH1N1.

    FluSure Pandemic and FluSure XP, essential parts of the FluSure XP Defense System™, help guard against 9 out of 10 of the most current flu strains that threaten swine herds today.1 

    Challenge and serologic studies in pigs vaccinated with this vaccine show reduced both viral shedding and lung lesions, as well as increased titers against pH1N1.2,3 

    Amphigen®  is the adjuvant in FluSure Pandemic. This adjuvant helps provide an excellent immune response and provides a high degree of safety, ease of use and syringeability. 

    1. Genetic comparison of viruses submitted to the University of Minnesota Veterinary Diagnostic Laboratory in the last three years demonstrated that 9 out of 10 currently circulating U.S. strains were at least 90% homologous to FluSure XP and/or FluSure Pandemic strains.
    2. Data on file, Study Report No. 3121R-60-09-792, Zoetis Inc.
    3. Data on file, Study Report No. 3125R-60-09-761, Zoetis Inc.

  • FluSure Pandemic is available in 50-dose and 250-dose sizes.

    Consult your veterinarian, as well as continue to follow the American Association of Swine Veterinarians and National Pork Producers Council recommendations for routine flue preventive measures.